Perioperative intravenous S(+)-ketamine for acute postoperative pain in adults: study protocol for a multicentre, randomised, open-label, positive-controlled, pragmatic clinical trial (SAFE-SK-A trial)

Hong Wang, Chong-Yang Duan, Wen-Qi Huang, Ping Zhao, Li-Zhi Zhou, Yan-Hong Liu, Cun-Ming Liu, Hai-Chen Chu, Qiang Wang, Yu-Gang Diao, Zhen Hua, Qing-Tao Meng, Hao Li, Xiao-Ying Zhang, Wei-Dong Mi, Ping-Yan Chen, Hong Wang, Chong-Yang Duan, Wen-Qi Huang, Ping Zhao, Li-Zhi Zhou, Yan-Hong Liu, Cun-Ming Liu, Hai-Chen Chu, Qiang Wang, Yu-Gang Diao, Zhen Hua, Qing-Tao Meng, Hao Li, Xiao-Ying Zhang, Wei-Dong Mi, Ping-Yan Chen

Abstract

Introduction: Postoperative pain remains incompletely controlled for decades. Recently, multimodal analgesia is emerging as a potential approach in the management of postoperative pain. Therein, S(+)-ketamine is appealing as an adjuvant drug in multimodal analgesia due to its unique pharmacological advantages. This pragmatic clinical trial (SAFE-SK-A trial) is designed to investigate the analgesic effect and safety of S(+)-ketamine for acute postoperative pain in adults and explore the optimal strategy of perioperative intravenous S(+)-ketamine in a real-world setting.

Methods and analysis: This multicentre, randomised, open-label, positive-controlled, pragmatic clinical trial (SAFE-SK-A study) is planned to conduct in 80 centres from China and recruit a total of 12 000 adult participants undergoing a surgical procedure under general anaesthesia. Patient recruitment started in June 2021 and will end in June 2022. Participants will be randomised in a ratio of 2:1 to either receive perioperative intravenous S(+)-ketamine plus conventional anaesthesia or conventional anaesthesia only. Given the pragmatic nature of the study, no specific restriction as to the administration dosage, route, time, synergistic regimen or basic analgesics. Primary endpoints are the area under the broken line of Numerical Rating Scale (NRS) scores for pain intensity and the total opioid consumption within 48 hours postoperative. Secondary endpoints are postoperative NRS scores, the anaesthesia recovery time, time of first rescue analgesia, the incidence of rescue analgesia, the incidence of postoperative delirium, patient questionnaire for effect, changes from baseline in cognitive function and anxiety and depression, as well as the adverse events and pharmacoeconomic outcomes. The general linear model will be used for the primary endpoint, and appropriate methods will be used for the secondary endpoints.

Ethics and dissemination: This trial has been approved by the local Institutional Review Board (S2021-026-02) and conducted following the Declaration of Helsinki. Results of this trial will be publicly disclosed and published in scientific journals.

Trial registration number: NCT04837170; Pre-results.

Keywords: S(+)-ketamine; acute postoperative pain; esketamine; multimodal analgesia; pragmatic clinical trial.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
Study outline. *The assessment at 72 hours postoperatively (visit 4) applies to patients who have not been discharged. NMDA, N-methyl-d-aspartate.

References

    1. Mitra S, Carlyle D, Kodumudi G, et al. . New advances in acute postoperative pain management. Curr Pain Headache Rep 2018;22:35. 10.1007/s11916-018-0690-8
    1. Rawal N. Current issues in postoperative pain management. Eur J Anaesthesiol 2016;33:160–71. 10.1097/EJA.0000000000000366
    1. Wu CL, Raja SN. Treatment of acute postoperative pain. Lancet 2011;377:2215–25. 10.1016/S0140-6736(11)60245-6
    1. Hurley RW, CL W. Acute postoperative pain. Miller’s Anesthesia 2010;7:2757–87.
    1. Kissin I, Weiskopf Richard B. Preemptive analgesia. Anesthesiology 2000;93:1138–43. 10.1097/00000542-200010000-00040
    1. Gan TJ. Poorly controlled postoperative pain: prevalence, consequences, and prevention. J Pain Res 2017;10:2287–98. 10.2147/JPR.S144066
    1. Khademi H, Kamangar F, Brennan P, et al. . Opioid therapy and its side effects: a review. Arch Iran Med 2016;19:870–6.
    1. Thiruvenkatarajan V, Wood R, Watts R, et al. . The intraoperative use of non-opioid adjuvant analgesic agents: a survey of anaesthetists in Australia and New Zealand. BMC Anesthesiol 2019;19:188. 10.1186/s12871-019-0857-9
    1. Helander EM, Menard BL, Harmon CM, et al. . Multimodal analgesia, current concepts, and acute pain considerations. Curr Pain Headache Rep 2017;21:3. 10.1007/s11916-017-0607-y
    1. Imani F, Varrassi G. Ketamine as adjuvant for acute pain management. Anesth Pain Med 2019;9:e100178. 10.5812/aapm.100178
    1. Richards JR, Rockford RE. Low-Dose ketamine analgesia: patient and physician experience in the ED. Am J Emerg Med 2013;31:390–4. 10.1016/j.ajem.2012.07.027
    1. Marland S, Ellerton J, Andolfatto G, et al. . Ketamine: use in anesthesia. CNS Neurosci Ther 2013;19:381–9. 10.1111/cns.12072
    1. Peltoniemi MA, Hagelberg NM, Olkkola KT, et al. . Ketamine: a review of clinical pharmacokinetics and pharmacodynamics in anesthesia and pain therapy. Clin Pharmacokinet 2016;55:1059–77. 10.1007/s40262-016-0383-6
    1. Wang X, Lin C, Lan L, et al. . Perioperative intravenous S-ketamine for acute postoperative pain in adults: a systematic review and meta-analysis. J Clin Anesth 2021;68:110071. 10.1016/j.jclinane.2020.110071
    1. Brinck EC, Tiippana E, Heesen M, et al. . Perioperative intravenous ketamine for acute postoperative pain in adults. Cochrane Database Syst Rev 2018;12:CD012033. 10.1002/14651858.CD012033.pub4
    1. Rybakowski JK, Permoda-Osip A, Bartkowska-Sniatkowska A. Ketamine: Its Safety, Tolerability, and Impact on Neurocognition. In: Mathew SJ, Zarate JCA, eds. Ketamine for treatment-resistant depression: the first decade of progress. Cham: Springer International Publishing, 2016: 57–71.
    1. Sloekers JCT, Bos M, Hoogland G, et al. . Assessing the effectiveness of perioperative s-ketamine on new-onset headache after resective epilepsy surgery (ESPAIN-trial): protocol for a randomised, double-blind, placebo-controlled trial. BMJ Open 2019;9:e030580. 10.1136/bmjopen-2019-030580
    1. Ho K-Y, Tay W, Yeo M-C, et al. . Duloxetine reduces morphine requirements after knee replacement surgery. Br J Anaesth 2010;105:371–6. 10.1093/bja/aeq158
    1. Spreng UJ, Dahl V, Ræder J. Effects of perioperative S (+) ketamine infusion added to multimodal analgesia in patients undergoing ambulatory haemorrhoidectomy. Scand J Pain 2010;1:100–5. 10.1016/j.sjpain.2010.01.001
    1. Wang J, Huang J, Yang S, et al. . Pharmacokinetics and safety of Esketamine in Chinese patients undergoing painless gastroscopy in comparison with ketamine: a randomized, open-label clinical study. Drug Des Devel Ther 2019;13:10.2147/DDDT.S224553:4135–44. 10.2147/DDDT.S224553
    1. Liu P, Li P, Li Q, et al. . Effect of pretreatment of S-Ketamine on postoperative depression for breast cancer patients. J Invest Surg 2021;34:1–6. 10.1080/08941939.2019.1710626
    1. Mendola C, Cammarota G, Netto R, et al. . S(+)-ketamine for control of perioperative pain and prevention of post thoracotomy pain syndrome: a randomized, double-blind study. Minerva Anestesiol 2012;78:22441361:757–66.
    1. Ithnin FB, Tan DJA, Xu XL, et al. . Low-Dose S+ ketamine in target-controlled intravenous anaesthesia with remifentanil and propofol for open gynaecological surgery: a randomised controlled trial. Indian J Anaesth 2019;63:10.4103/ija.IJA_605_18:126–33. 10.4103/ija.IJA_605_18

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe